Several reports have demonstrated that interferon-alpha (IFN-α) and interferon-beta (IFN-β) can down-regulate the expression and production of bFGF, leading to inhibition of angiogenesis in various human cancers (Singh et al, 1995; Dinney et al, 1998). The gene discussed is IFNB1; the disease is cancer.